© 1988 by Oxford University Press
Head Trauma and Exposure to Prolactin-Elevating Drugs as Risk Factors for Male Breast Cancer
Hakan Olsson and Jonas Ranstam
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Oncology..Male Breast Cancer
- Medicine..Breast Issues
- Oncology..Treatment Options for Breast Cancer
- Oncology..Breast Cancer
- Oncology..Epidemiology, Causes, and Risk Factors of Breast Cancer
- Biochemistry..Prolactin
- Physiology..Estrogen
- Oncology..Hereditary Causes of Breast Cancer
- Oncology..Genetic Causes of Cancer
- Oncology..Diet and Nutrition
- Medicine..Gynecomastia
- Oncology..Treatment Options for Lung Cancer
- Oncology..Epidemiology, Causes, and Risks of Lung Cancer
- Oncology..Genetics of Breast Cancer
This article has been cited by other articles:
![]() |
L. A. Brinton, D. A. Richesson, G. L. Gierach, J. V. Lacey Jr, Y. Park, A. R. Hollenbeck, and A. Schatzkin Prospective Evaluation of Risk Factors for Male Breast Cancer J Natl Cancer Inst, October 15, 2008; 100(20): 1477 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Arendt and L. A. Schuler Prolactin Drives Estrogen Receptor-{alpha}-Dependent Ductal Expansion and Synergizes with Transforming Growth Factor-{alpha} to Induce Mammary Tumors in Males Am. J. Pathol., January 1, 2008; 172(1): 194 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Weiss, K. B. Moysich, and H. Swede Epidemiology of Male Breast Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 20 - 26. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


